SHERRA CARR: Open Payments
NPI 1851648802 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 88 payments from 11 companies in 2025. Trend: 2023 $1,355 · 2024 $1,714 · 2025 $1,453
Food & beverage: $1,453
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $512 |
| Novartis Pharmaceuticals Corporation | 22 | $385 |
| Amgen Inc. | 23 | $275 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| Janssen Biotech, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $38 |
| ANI Pharmaceuticals, Inc. | 2 | $37 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| UCB, Inc. | 1 | $19 |
Products named: COSENTYX, SKYRIZI, Otezla, RINVOQ, ORENCIA, KRYSTEXXA, TREMFYA, PURIFIED CORTROPHIN GEL.
Industry payments across MS — which companies pay providers there.
